Boston Scientific Co
BSX
Real-time BATS EXCHANGE - 08/17 03:35:01 pm
34.48USD
+0.55%
Prev.34.2900
Open35.0000
High35.0600
Low34.1600
Volume7 195 775
Financials
Sales 2018 9 849 M
EBIT 2018 2 487 M
R. net 2018 1 389 M
Debt 2018 4 650 M
Rend. 2018 -
P/E ratio 2018 33,13
P/E ratio 2019 29,31
EV / Sales 2018 5,37x
EV / Sales 2019 4,92x
Capitalization 48 250 M
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.The Cardiovascular segment comprises of technologies or...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2018-10-25 Earnings Release
Trading Rating :
Investor Rating :
Latest news
08/15LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET IS TRENDING WITH CAGR OF 30.6% BY 2024 BOSTON SCIENTIFIC, COHEREX MEDICAL, ST JUDE MEDICAL, ARTICURE, SENTREHEART : "Left Atrial Appendage Closure Device Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2024” with coming years Industries Trends, projections of Global Growth, Major key player and Case study, Review, Share, Size, Effect.
AQ
08/10BOSTON SCIENTIFIC : to acquire Veniti for $160M
AQ
08/09BOSTON SCIENTIFIC : St. Louis startup Veniti to be bought in $160 million deal
AQ
08/08BOSTON SCIENTIFIC CORP : Regulation FD Disclosure (form 8-K)
AQ
08/08BOSTON SCIENTIFIC : Announces Agreement to Acquire VENITI, Inc.
PR
08/06BOSTON SCIENTIFIC : 65-- 583v87809-icd implant-boston scientific
AQ
08/04BOSTON SCIENTIFIC : Federal Contracts Awarded by Federal Agencies in Indiana (Aug. 4)
AQ
08/04BOSTON SCIENTIFIC : $7,000 Federal Contract Awarded to Boston Scientific
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance34,934,938,3
Spread/Res.-1,7%-1,7%-10%
Spread/Supp.1,0%14%16%
Support34,030,229,4